Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors.
about
Herbal medicine use and linked suspected adverse drug reactions in a prospective cohort of Ugandan inpatientsRandomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infectionIncidence and predictors of first line antiretroviral regimen modification in western KenyaIncidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatientsPredictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda.Three-year outcome data of second-line antiretroviral therapy in Ugandan adults: good virological response but high rate of toxicity.Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America.Knowledge, beliefs, and health care practices relating to treatment of HIV in Vellore, India.Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.Prevalence and factors associated with traditional herbal medicine use among patients on highly active antiretroviral therapy in Uganda.Incidence and predictors of regimen-modification from first-line antiretroviral therapy in Thailand: a cohort studyTherapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety studyThe Reason for Regimen Change Among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia.Antiretroviral treatment interruption and loss to follow-up in two HIV cohorts in Australia and Asia: implications for 'test and treat' prevention strategy.Differential survival benefit of universal HAART access in Brazil: a nation-wide comparison of injecting drug users versus men who have sex with men.Economic evaluation of ART in resource-limited countries.Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.Women, economic hardship and the path of survival: HIV/AIDS risk behavior among women receiving HIV/AIDS treatment in Uganda.Choice of initial antiretroviral drugs and treatment outcomes among HIV-infected patients in sub-Saharan Africa: systematic review and meta-analysis of observational studies.Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.Switch to second-line ART in West African routine care: incidence and reasons for switching.Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.Reasons and predictors for antiretroviral therapy change among HIV-infected adults at South West Ethiopia.
P2860
Q27308919-8CFC6D08-37F4-49AC-B2E5-1670F4078586Q28478848-975959D8-A3BD-488C-970A-D7C5EBE344F1Q28541822-4347A559-54D6-48E8-9F17-604E567EFF10Q28559384-B29CD40E-C503-4CEC-A599-FBD8549BA6FFQ30997469-D2DFB71F-36D3-42CF-AC0A-69BE80D15296Q33394513-C33234B9-BA55-4F8E-8293-9FEC0CB08BB6Q33598309-E3C1B99F-B1DA-4018-BDAD-EE31828C936FQ33797562-AB6E7616-7AF3-4C62-90D5-99655215FC89Q33999150-7D4472B9-7527-4618-A65D-3EED198668FAQ34072215-14443735-C7F5-4C7B-A832-930BC7BF8368Q34484483-DC8368F0-2899-4D29-A125-24747F227B11Q34711266-84205060-A12E-4E92-834D-B8953A218A64Q35787655-161C0382-4743-40D0-ADCC-BA27A90A4C54Q37404322-8A9132C3-38E1-4A06-B766-BADE151CDDE6Q37455505-A4229DFC-4724-49FA-836E-6F94ED6B285AQ37503832-BE689F48-E871-4A84-A268-59285E082883Q38452483-026334A8-3329-4D7F-A4C5-CCC0F21E217BQ38874761-BE8491E0-FF4F-4068-928D-AEC4CC69AD84Q40070125-17B0CD6F-509C-4552-BF68-4577D8A6F50AQ40373312-E7A1B136-42CD-4E2F-A4F3-7C96EDEB31E0Q44680504-F3DA9E3D-B6E3-4A57-BBBD-EEA8F0B4822EQ46867082-385BD1B4-2361-40B0-8D3E-DCB1A76E9B85Q55257500-8C4E33BB-7350-4F0C-B6EF-369C7E9099A3
P2860
Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Discontinuation and modificati ...... alence and associated factors.
@en
type
label
Discontinuation and modificati ...... alence and associated factors.
@en
prefLabel
Discontinuation and modificati ...... alence and associated factors.
@en
P2093
P1476
Discontinuation and modificati ...... alence and associated factors.
@en
P2093
Charles Karamagi
Francis Ssali
Jayne Byakika-Tusiime
Peter Mugyenyi
P304
P356
10.1097/QAI.0B013E31805D8AE3
P407
P577
2007-06-01T00:00:00Z